Group-by-Treatment Interaction: Rejoinder [General Sta­tis­tics]

posted by Helmut Homepage – Vienna, Austria, 2024-12-17 11:26 (157 d 08:31 ago) – Posting: # 24320
Views: 2,357

Dear all,

submitted 6 October 2024, accepted 4 December 2024 (only one review round and not three as in our original paper), online yesterday.

Helmut Schütz , Divan A Burger , Erik Cobo , David Dubins , Tibor Farkás, Detlew Labes , Benjamin Lang, Jordi Ocaña, Arne Ring , Anastasia Shitova , Volodymyr Stus, Michael Tomashevskiy.
Rejoinder to the ‘Letter to the Editor’ on “Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies”.
AAPS J. 2025; 27(1): 14. doi:10.1208/s12248-024-01008-3. [image] View-only version.


Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,681 registered users;
59 visitors (0 registered, 59 guests [including 38 identified bots]).
Forum time: 20:57 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5